Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Dierich

Showing results (281-290 of 337) with videos related to

Pageof 34
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 14, 2002
Escherichia coli O157 infections and unpasteurised milkF Allerberger, M Wagner, P Schweiger, et al.
AIDS (London, England)|October 1, 1990
Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937E C Reisinger, W Vogetseder, D Berzow, et al.
Journal of Virology|July 11, 1998
Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophagesL Kacani, I Frank, M Spruth, et al.
Blood|February 7, 2001
Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21)M W Hess, M G Schwendinger, E L Eskelinen, et al.
AIDS (London, England)|July 1, 1993
HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cellsP Marschang, L Gürtler, M Tötsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1996
Identification and characterization of complement C3 receptors on human astrocytesP Gasque, P Chan, C Mauger, et al.
Immunology Letters|May 1, 1989
Interaction between C3 and IL-2; inhibition of C3b binding to CR1 by IL-2I Bartók, A Erdei, A Mouzaki, et al.
European Journal of Haematology|February 1, 1993
Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infectionD Fuchs, R Zangerle, E Artner-Dworzak, et al.
Immunobiology|November 1, 1991
Macrophage tumor cell interaction is enhanced by C3 fragmentsM Lipari, L di Renzo, A Zicari, et al.
Lupus|January 11, 2007
Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue diseaseM Scherl, U Posch, G Obermoser, et al.
Pageof 34

Showing results (281-290 of 337) with videos related to

Sort By:
Pageof 34
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 14, 2002
Escherichia coli O157 infections and unpasteurised milkF Allerberger, M Wagner, P Schweiger, et al.
AIDS (London, England)|October 1, 1990
Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937E C Reisinger, W Vogetseder, D Berzow, et al.
Journal of Virology|July 11, 1998
Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophagesL Kacani, I Frank, M Spruth, et al.
Blood|February 7, 2001
Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21)M W Hess, M G Schwendinger, E L Eskelinen, et al.
AIDS (London, England)|July 1, 1993
HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cellsP Marschang, L Gürtler, M Tötsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1996
Identification and characterization of complement C3 receptors on human astrocytesP Gasque, P Chan, C Mauger, et al.
Immunology Letters|May 1, 1989
Interaction between C3 and IL-2; inhibition of C3b binding to CR1 by IL-2I Bartók, A Erdei, A Mouzaki, et al.
European Journal of Haematology|February 1, 1993
Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infectionD Fuchs, R Zangerle, E Artner-Dworzak, et al.
Immunobiology|November 1, 1991
Macrophage tumor cell interaction is enhanced by C3 fragmentsM Lipari, L di Renzo, A Zicari, et al.
Lupus|January 11, 2007
Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue diseaseM Scherl, U Posch, G Obermoser, et al.
Pageof 34